Related Experiment Video
Updated: May 18, 2026
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Transradial percutaneous iliac intervention, a feasible alternative to the transfemoral route
Bernardo Cortese1, Elisa Peretti, Nicola Troisi
1Interventional Cardiology, A.O. Fatebenefratelli,Bastioni diPorta Nuova 21, Milan, Italy. bcortese@gmail.com
Insights
The transradial approach is feasible for treating atherosclerotic iliac disease, offering similar procedural times to the transfemoral route in experienced hands. Further research is needed to confirm its safety profile.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Peripheral Artery Disease
Background:
- Percutaneous angioplasty for iliac artery disease typically uses femoral or brachial access.
- Transradial approach reduces bleeding in coronary interventions but is less studied for peripheral procedures.
Purpose of the Study:
- Evaluate the feasibility and safety of the transradial approach for iliac artery interventions.
- Compare transradial versus transfemoral approaches in terms of procedural success, duration, and short-term outcomes.
Main Methods:
- A consecutive series of 42 patients undergoing percutaneous iliac intervention were analyzed.
- 21 patients received transradial access, and 21 received transfemoral access.
- Procedural success, procedure duration, and one-month event-free survival were key endpoints.
Main Results:
- All interventions achieved procedural success regardless of access route.
- No significant differences were observed in procedure duration or one-month clinical follow-up between the groups.
- Technical aspects of the transradial approach were detailed.
Conclusions:
- Transradial access is a feasible option for atherosclerotic iliac disease treatment.
- This approach does not prolong procedural time in experienced hands.
- Additional studies are required to ascertain the safety of transradial versus transfemoral access.
Background:
Percutaneous angioplasty for atherosclerotic iliac disease is commonly performed via the femoral and/or brachial route. In the coronary field a transradial approach has been shown to reduce both major and minor access site bleedings, in experienced hands. However, this route has not yet been well studied for the majority of peripheral interventions, like those involving the iliac arteries.
Methods:
We investigated the feasibility and safety of a transradial approach in a consecutive series of patients undergoing percutaneous iliac intervention at our center, comparing it to a similar series of patients treated with a transfemoral approach in the same period. Endpoints of the study were procedural success, duration of procedure and event free survival at one month.
Results:
From our database we enrolled 42 patients undergone iliac percutaneous interventions (21 with a transradial and 21 with a transfemoral approach); the 2 populations had similar baseline characteristics. Procedural success was achieved in all of our patient population. Among the secondary study endpoints analyzed we observed similar duration of the procedure and one-month clinical follow up. Technical aspects of the transradial approach are discussed.
Conclusions:
A transradial approach is feasible for the treatment of atherosclerotic iliac disease and does not increase procedural time in experienced hands. Further studies are needed to confirm if this approach is as safe as the transfemoral one.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
01:19Imaging Studies VII: Vascular Imaging